scholarly journals Insights from quantitative and mathematical modelling on the proposed WHO 2030 goal for schistosomiasis

2019 ◽  
Vol 3 ◽  
pp. 1517
Author(s):  
Keyword(s):  
Treatment Guidelines ◽  
Neglected Tropical Diseases ◽  
Public Health Problem ◽  
Control Measures ◽  
World Health ◽  
School Aged Children ◽  
High Prevalence ◽  
The World ◽  
Health Organization ◽  
The Impact

Schistosomiasis remains one of the neglected tropical diseases (NTDs) impacting millions of people around the world. The World Health Organization (WHO) recently proposed a goal of elimination as a public health problem (EPHP) for schistosomiasis to be reached by 2030. Current WHO treatment guidelines for achieving EPHP focus on targeting school-aged children. The NTD Modelling Consortium has developed mathematical models to study schistosomiasis transmission dynamics and the impact of control measures. Our modelling insights on Schistosoma mansoni have shown that EPHP is likely to be attainable in low to moderate prevalence settings using the current guidelines. However, as prevalence rises within high prevalence settings, EPHP is less likely to be achieved unless both school-aged children and adults are treated (with coverage levels increasing with the adult burden of infection). We highlight the challenges that are faced by treatment programmes, such as non-adherence to treatment and resurgence, which can hinder progress towards achieving and maintaining EPHP. Additionally, even though EPHP may be reached, prevalence can still be high due to persisting infections. Therefore, without interruption of transmission, treatment will likely have to continue to maintain EPHP. Further modelling work is being carried out, including extending our results to S. haematobium. By providing these modelling insights, we aim to inform discussions on the goals and treatment guidelines for schistosomiasis.

scholarly journals Insights from quantitative and mathematical modelling on the proposed WHO 2030 goal for schistosomiasis

2019 ◽  
Vol 3 ◽  
pp. 1517 ◽  
Author(s):  
Keyword(s):  
Treatment Guidelines ◽  
Neglected Tropical Diseases ◽  
Public Health Problem ◽  
Control Measures ◽  
World Health ◽  
School Aged Children ◽  
The World ◽  
Health Organization ◽  
The Impact ◽  
Current Guidelines

Schistosomiasis remains one of the neglected tropical diseases (NTDs) impacting millions of people around the world. The World Health Organization (WHO) recently proposed a goal of elimination as a public health problem (EPHP) for schistosomiasis to be reached by 2030. Current WHO treatment guidelines for achieving EPHP focus on targeting school-aged children. The NTD Modelling Consortium has developed mathematical models to study schistosomiasis transmission dynamics and the impact of control measures. Our modelling insights on Schistosoma mansoni have shown that EPHP is likely to be attainable in low to moderate prevalence settings using the current guidelines. However, as prevalence rises within higher settings, EPHP is less likely to be achieved unless both school-aged children and adults are treated (with coverage levels increasing with the adult burden of infection). We highlight the challenges that are faced by treatment programmes, such as non-adherence to treatment and resurgence, which can hinder progress towards achieving and maintaining EPHP. Additionally, even though EPHP may be reached, prevalence can still be high due to persisting infections. Therefore, without elimination of transmission, treatment will likely have to continue to maintain EPHP. Further modelling work is being carried out, including extending our results to S. haematobium. By providing these modelling insights, we aim to inform discussions on the goals and treatment guidelines for schistosomiasis.

Characterizing the effectiveness of COVID-19 mitigation measures: A data-centric approach (Preprint)

2020 ◽  
Author(s):  
Lukman Olagoke ◽  
Ahmet E. Topcu
Keyword(s):  
Control Measure ◽  
Control Measures ◽  
World Health ◽  
Mitigation Measures ◽  
Effective Control ◽  
The World ◽  
Decision Making Processes ◽  
And Performance ◽  
Health Organization ◽  
The Impact

BACKGROUND COVID-19 represents a serious threat to both national health and economic systems. To curb this pandemic, the World Health Organization (WHO) issued a series of COVID-19 public safety guidelines. Different countries around the world initiated different measures in line with the WHO guidelines to mitigate and investigate the spread of COVID-19 in their territories. OBJECTIVE The aim of this paper is to quantitatively evaluate the effectiveness of these control measures using a data-centric approach. METHODS We begin with a simple text analysis of coronavirus-related articles and show that reports on similar outbreaks in the past strongly proposed similar control measures. This reaffirms the fact that these control measures are in order. Subsequently, we propose a simple performance statistic that quantifies general performance and performance under the different measures that were initiated. A density based clustering of based on performance statistic was carried out to group countries based on performance. RESULTS The performance statistic helps evaluate quantitatively the impact of COVID-19 control measures. Countries tend show variability in performance under different control measures. The performance statistic has negative correlation with cases of death which is a useful characteristics for COVID-19 control measure performance analysis. A web-based time-line visualization that enables comparison of performances and cases across continents and subregions is presented. CONCLUSIONS The performance metric is relevant for the analysis of the impact of COVID-19 control measures. This can help caregivers and policymakers identify effective control measures and reduce cases of death due to COVID-19. The interactive web visualizer provides easily digested and quick feedback to augment decision-making processes in the COVID-19 response measures evaluation. CLINICALTRIAL Not Applicable

scholarly journals Development of a public geographical information system-based website to follow the impact of control activities of soil-transmitted helminths in endemic countries

2021 ◽  
Vol 16 (2) ◽  
Author(s):  
Maria Paola Maurelli ◽  
Paola Pepe ◽  
Antonio Montresor ◽  
Denise Mupfasoni ◽  
Martina Nocerino ◽  
...  
Keyword(s):  
Neglected Tropical Diseases ◽  
Mortality Rates ◽  
Geographical Information ◽  
World Health ◽  
High Morbidity ◽  
Preventive Chemotherapy ◽  
The World ◽  
Pharmaceutical Industries ◽  
Health Organization ◽  
The Impact

Soil-transmitted helminth (STH) infections are among the most common neglected tropical diseases worldwide causing high morbidity and mortality rates in endemic areas. Preventive chemotherapy (PC) programmes and health education are recommended by the World Health Organization (WHO) to reduce the impact of STH in endemic countries. Following our role as WHO collaborating centre (WHO CC ITA-116), we have developed a WebGIS and a dataset to support PC programmes to monitor the impact of STH control. This vHealth presentation shows the potentiality of these tools in improving communication among WHO’s regional and country offices, Ministries of Health, pharmaceutical industries and other partners.

scholarly journals Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution

2020 ◽  
Vol 221 (Supplement_5) ◽  
pp. S519-S524
Author(s):  
William Godwin ◽  
Joaquin M Prada ◽  
Paul Emerson ◽  
P J Hooper ◽  
Ana Bakhtiari ◽  
...  
Keyword(s):  
Public Health ◽  
Diagnostic Tests ◽  
Public Health Problem ◽  
World Health ◽  
Simulation Based ◽  
The World ◽  
Health Organization ◽  
Program Cycle ◽  
The Impact ◽  
Oral Azithromycin

Abstract Background As the World Health Organization seeks to eliminate trachoma by 2020, countries are beginning to control the transmission of trachomatous inflammation–follicular (TF) and discontinue mass drug administration (MDA) with oral azithromycin. We evaluated the effect of MDA discontinuation on TF1–9 prevalence at the district level. Methods We extracted from the available data districts with an impact survey at the end of their program cycle that initiated discontinuation of MDA (TF1–9 prevalence <5%), followed by a surveillance survey conducted to determine whether TF1–9 prevalence remained below the 5% threshold, warranting discontinuation of MDA. Two independent analyses were performed, 1 regression based and 1 simulation based, that assessed the change in TF1–9 from the impact survey to the surveillance survey. Results Of the 220 districts included, TF1–9 prevalence increased to >5% from impact to surveillance survey in 9% of districts. Regression analysis indicated that impact survey TF1–9 prevalence was a significant predictor of surveillance survey TF1–9 prevalence. The proportion of simulations with >5% TF1–9 prevalence in the surveillance survey was 2%, assuming the survey was conducted 4 years after MDA. Conclusion An increase in TF1–9 prevalence may represent disease resurgence but could also be due to measurement error. Improved diagnostic tests are crucial to elimination of TF1–9 as a public health problem.

scholarly journals Achieving the Endgame: Integrated NTD Case Searches

2018 ◽  
Author(s):  
Lucas Buyon ◽  
Randall Slaven ◽  
Paul M. Emerson ◽  
Jonathan King ◽  
Oscar Debrah ◽  
...  
Keyword(s):  
Case Management ◽  
Neglected Tropical Diseases ◽  
Point Of Care ◽  
Management Strategies ◽  
Public Health Problem ◽  
World Health ◽  
Management Approach ◽  
Guinea Worm ◽  
The World ◽  
Health Organization

AbstractTrachoma and Guinea Worm Disease (GWD) are neglected tropical diseases (NTDs) slated for elimination as a public health problem and eradication respectively by the World Health Organization. As these programs wind down, uncovering the last remaining cases becomes an urgent priority. In 2010, The Ghana Health Service, along with The Carter Center, Sightsavers, and other partners, conducted integrated case search for cases of both GWD and the last stage of trachoma disease, trachomatous trichiasis (TT), as well as providing treatment for trachoma to meet elimination and eradication targets. House to house case search for both diseases was conducted and two case management strategies were explored: a centralized referral to services method and a Point of Care (POC) delivery method. 835 suspected TT cases were discovered in the centralized method, of which 554 accepted surgery. 482 suspected TT cases were discovered in the POC method and all TT cases accepted surgery in the POC searches. The cost per TT case examined was lower in the POC searches compared to the centralized searches ($19.97 in the POC searches and $20.85 in the centralized searches). Both strategies resulted in high surgical uptake for TT surgery, with average uptakes of 72.4% and 83.9% for the centralized and POC searches respectively. We present here that house to house case search offering services at POC are feasible and a potential tool for elimination and eradication programs nearing their end.Author SummaryTrachoma and Guinea Worm Disease (GWD) are neglected tropical diseases (NTDs) slated for elimination as a public health problem and eradication respectively by the World Health Organization. As these programs wind down, uncovering the last remaining cases becomes an urgent priority in order to confirm that eradiation/elimination targets have been reached. Active case searches are one method of finding these last vestiges of disease. Searches for that look for multiple diseases are referred to as integrated searches. We piloted here integrated case searches for GWD and Trachoma with two case management strategies, a referral approach to a central location, and point of care approach (POC). POC approaches can difficult to implement in low resource settings because they require extensive personnel, financial, and logistical, support. However, POC approaches remove one of the biggest barriers to treatment, time spent traveling to a health center, and thus can improve treatment uptake. We found here that integrated active cases searches with a POC case management approach can be implemented in a low resource setting; and improve acceptance and uptake of trachoma examination and trichiasis surgery respectively without costing much more than the referral case management approach.

scholarly journals Modelling the ability of mass drug administration to interrupt soil-transmitted helminth transmission: Community-based deworming in Kenya as a case study

2021 ◽  
Vol 15 (8) ◽  
pp. e0009625
Author(s):  
Nyuk Sian Chong ◽  
Stacey R. Smith? ◽  
Marleen Werkman ◽  
Roy M. Anderson
Keyword(s):  
Drug Administration ◽  
Mass Drug Administration ◽  
Neglected Tropical Diseases ◽  
Initial Conditions ◽  
Drug Efficacy ◽  
World Health ◽  
High Prevalence ◽  
Lower Drug ◽  
Health Organization ◽  
The Impact

The World Health Organization has recommended the application of mass drug administration (MDA) in treating high prevalence neglected tropical diseases such as soil-transmitted helminths (STHs), schistosomiasis, lymphatic filariasis, onchocerciasis and trachoma. MDA—which is safe, effective and inexpensive—has been widely applied to eliminate or interrupt the transmission of STHs in particular and has been offered to people in endemic regions without requiring individual diagnosis. We propose two mathematical models to investigate the impact of MDA on the mean number of worms in both treated and untreated human subpopulations. By varying the efficay of drugs, initial conditions of the models, coverage and frequency of MDA (both annual and biannual), we examine the dynamic behaviour of both models and the possibility of interruption of transmission. Both models predict that the interruption of transmission is possible if the drug efficacy is sufficiently high, but STH infection remains endemic if the drug efficacy is sufficiently low. In between these two critical values, the two models produce different predictions. By applying an additional round of biannual and annual MDA, we find that interruption of transmission is likely to happen in both cases with lower drug efficacy. In order to interrupt the transmission of STH or eliminate the infection efficiently and effectively, it is crucial to identify the appropriate efficacy of drug, coverage, frequency, timing and number of rounds of MDA.

scholarly journals The impact of COVID-19 pandemic on AIDS-related mycoses and fungal neglected tropical diseases: Why should we worry?

2021 ◽  
Vol 15 (2) ◽  
pp. e0009092
Author(s):  
Sanaz Nargesi ◽  
Felix Bongomin ◽  
Mohammad T. Hedayati
Keyword(s):  
Neglected Tropical Diseases ◽  
Fungal Infections ◽  
Healthcare Systems ◽  
World Health ◽  
Tropical Diseases ◽  
New Wave ◽  
The World ◽  
Health Organization ◽  
Therapeutic Research ◽  
The Impact

The World Health Organization (WHO) considers mycetoma, chromoblastomycosis, and paracoccidioidomycosis to be fungal neglected tropical diseases (FNTDs). Depending on climatic, cultural, and economic contexts, these diseases have a similar geographical distribution as many other diseases, particularly tuberculosis (TB) and malaria, but are often less targeted by the national and many international healthcare systems. Another subgroup of fungal infections, such as candidiasis, cryptococcosis, pneumocystosis, histoplasmosis, and to a lesser extent, aspergillosis, are known as AIDS-related mycoses. Although antiretroviral therapy (ART) has been able to decrease the mortality rate of these diseases, particularly cryptococcosis, the disproportionately low distribution of funds to their diagnosis and treatment remains an obstacle in saving and improving the lives of patients affected. A new wave of viral diseases dubbed the Coronavirus Disease 2019 (COVID-19) hit the world at the end of 2019. Due to progressive symptoms and high mortality rates of COVID-19 compared to fungal infections, particularly the FNTDs, funding is currently allocated predominantly for diagnostic and therapeutic research on COVID-19. As a result, advances in FNTDs and AIDS-related mycosis care are considerably reduced. This paper explores the association between COVID-19, FNTDs, and AIDS-related mycoses with a predictive perspective.

scholarly journals Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?

2018 ◽  
Vol 66 (suppl_4) ◽  
pp. S245-S252 ◽  
Author(s):  
Jaspreet Toor ◽  
Ramzi Alsallaq ◽  
James E Truscott ◽  
Hugo C Turner ◽  
Marleen Werkman ◽  
...  
Keyword(s):  
World Health Organization ◽  
Public Health Problem ◽  
Monitoring And Evaluation ◽  
Wash Water ◽  
World Health ◽  
Treatment Coverage ◽  
Hygiene Measures ◽  
High Prevalence ◽  
The World ◽  
Health Organization

Abstract Background Schistosomiasis remains an endemic parasitic disease affecting millions of people around the world. The World Health Organization (WHO) has set goals of controlling morbidity to be reached by 2020, along with elimination as a public health problem in certain regions by 2025. Mathematical models of parasite transmission and treatment impact have been developed to assist in controlling the morbidity caused by schistosomiasis. These models can inform and guide implementation policy for mass drug administration programs, and help design monitoring and evaluation activities. Methods We use these models to predict whether the guidelines set by the WHO are on track for achieving their 2020 goal for the control of morbidity, specifically for Schistosoma mansoni. We examine whether programmatic adaptations; namely increases in treatment coverage and/or expansion to adult inclusion in treatment, will improve the likelihood of reaching the WHO goals. Results We find that in low-prevalence settings, the goals are likely to be attainable under current WHO guidelines, but in moderate to high-prevalence settings, the goals are less likely to be achieved unless treatment coverage is increased and expanded to at least 85% for school-aged children and 40% for adults. Conclusions To improve the likelihood of reaching the WHO goals, programmatic adaptations are required, particularly for moderate- to high-prevalence settings. Furthermore, improvements in adherence to treatment, potential development of candidate vaccines, and enhanced snail control and WASH (water, sanitation, and hygiene) measures will all assist in achieving the goals.

scholarly journals CÓMO DETECTAR SARS-CoV-2 EMPLEANDO PRUEBAS DE LABORATORIO

2020 ◽  
Vol 3 (9) ◽  
pp. 87-104
Author(s):  
JAZMIN DE LA LUZ ARMENDARIZ ◽  
LUIS GÓMEZ NÚÑEZ ◽  
Catalina Tufiño Loza ◽  
Manuel Zapata Moreno ◽  
María Concepción Chávez Flores ◽  
...  
Keyword(s):  
Clinical Signs ◽  
Control Measures ◽  
World Health ◽  
Serum Samples ◽  
Serological Tests ◽  
Infected People ◽  
Degree Of Protection ◽  
The World ◽  
Health Organization ◽  
The Impact

The SARS-CoV-2 virus is an emerging coronavirus identified in 2019 and is responsible for the disease called COVID-19, which was declared a global pandemic, in 2020 by the World Health Organization (WHO). At the beginning of May 2020, more than 4 million infected people have been confirmed in the world and more than 278 thousand deaths, estimating an economic impact of more than 3 billion dollars. In Mexico, a total of 36,327 positive cases have been confirmed. The impact of this disease is mainly associated with the rapid spread among the human population and the severity of the clinical signs, which, if not treated, can lead to death. Currently, there is no vaccine available to prevent the disease and its control is based on the clinical diagnosis, which must be carried out by a specialist. This diagnosis must be confirmed by laboratory tests, which are of two types, mainly: for the detection of the etiological agent (virological and molecular) and serological (detection of antibodies), both tests must be carried out by institutions approved by the InDRE. The objective of molecular diagnosis (which is the most widely used worldwide) is to identify a fragment of the viral genome, which would indicate that the individual has had exposure and has been infected with SARS-CoV-2. In the case of serological tests, the diagnosis is based on identifying the presence of specific antibodies in serum samples from patients in the convalescent phase, with this test the degree of protection in a population can be evaluated. Both types of tests can be performed in patients with or without symptoms and are of utmost importance for the establishment of prevention and control measures for this pandemic.

scholarly journals The roadmap towards elimination of lymphatic filariasis by 2030: insights from quantitative and mathematical modelling

2019 ◽  
Vol 3 ◽  
pp. 1538 ◽  
Author(s):  
Keyword(s):  
Public Health ◽  
Lymphatic Filariasis ◽  
Health Problem ◽  
Neglected Tropical Diseases ◽  
Public Health Problem ◽  
World Health ◽  
Basic Care ◽  
The World ◽  
Health Organization ◽  
Initial Target

The Global Programme to Eliminate Lymphatic Filariasis was launched in 2000 to eliminate lymphatic filariasis (LF) as a public health problem by 1) interrupting transmission through mass drug administration (MDA) and 2) offering basic care to those suffering from lymphoedema or hydrocele due to the infection. Although impressive progress has been made, the initial target year of 2020 will not be met everywhere. The World Health Organization recently proposed 2030 as the new target year for elimination of lymphatic filariasis (LF) as a public health problem. In this letter, LF modelers of the Neglected Tropical Diseases (NTDs) Modelling Consortium reflect on the proposed targets for 2030 from a quantitative perspective. While elimination as a public health problem seems technically and operationally feasible, it is uncertain whether this will eventually also lead to complete elimination of transmission. The risk of resurgence needs to be mitigated by strong surveillance after stopping interventions and sometimes perhaps additional interventions.

Sign in / Sign up

Export Citation Format

Share Document